[서울=뉴스핌] Reporter Baek Ji-hyeon = The Korea Exchange has decided to postpone the substantive review of Osstem Implant’s listing eligibility. Accordingly, a decision on whether or not to be subject to substantive examination will be decided within February 17, 15 trading days later.
On the 24th, the Exchange announced in a public notice, “We are reviewing whether Osstem Implant falls under the substantive examination for listing eligibility. .
“We plan to decide whether or not to be subject to the listing eligibility substantive examination by the 17th of next month and inform about the continuation or cancellation of trading suspension,” he said.
On the 3rd, Osstem Implant disclosed the fact of embezzlement by an employee of the fund team, and the transaction was suspended due to the substantive examination of listing eligibility. The amount of embezzlement was 221.5 billion won, exceeding its equity capital of 207.4 billion won as of the end of 2020.
Previously, the company denied concerns about capital erosion, saying, “Based on the net profit results up to the third quarter of last year, the amount of loss in accounting is about billions of won.”
| [서울=뉴스핌] Reporter Hwang Jun-seon = Osstem Implant’s manager of money management, Mr. Lee, embezzled 188 billion won from the company and bought Dongjin Semicam’s stock, causing a stir. The embezzlement case is the largest among listed companies, and as the Korea Exchange suspends trading of Osstem Implant’s stock, shareholders’ anxiety is growing. The photo shows the Osstem Implant office building in Gangseo-gu, Seoul on the morning of the 4th. 2022.01.04 hwang@newspim.com |
lovus23@newspim.com
